Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapyChen Yang, Cun Wang, Haigang Geng et al.|Cancer Cell|2024Cited by 70
Blockade of TNF-α/TNFR2 signalling suppresses colorectal cancer and enhances the efficacy of anti-PD1 immunotherapy by decreasing CCR8+T regulatory cellsYixian Guo, Wenyi Zhao, Ning Li et al.|Journal of Molecular Cell Biology|2023Cited by 35
High-level of intratumoral GITR+ CD4 T cells associate with poor prognosis in gastric cancerShouyu Ke, Wenyi Zhao, Feng Xie et al.|iScience|2022Cited by 10